A Study of ICP-033 in Patients With Advanced Solid Tumors

Clinical trial NCT05367232 · UNKNOWN

Trial details

NCT number: NCT05367232
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Patients With Advanced Solid Tumors

Start date: 2022-02-25
Primary completion: 2024-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.